바로가기메뉴

본문 바로가기 주메뉴 바로가기
 

logo

  • KOREAN
  • P-ISSN1226-6396
  • E-ISSN2234-4942
  • KCI

Trend Review of Traditional Chinese Medicine Studies on Pharmacopuncture Treatment for Post-Stroke Depression

Journal of Oriental Neuropsychiatry / Journal of Oriental Neuropsychiatry, (P)1226-6396; (E)2234-4942
2021, v.32 no.3, pp.235-245
https://doi.org/10.7231/jon.2021.32.3.235
Lee, Yeogyeong
Khang, Hyunjin
Song, Geumju
Oh, Jiyeon
Kim, Sangbeom
Kim, Jongmin
Park, Sejin

Abstract

Objectives: To provide clinical evidence of pharmacopuncture treatment for post-stroke depression by reviewing randomized controlled trials on Traditional Chinese medicine pharmacopuncture for post-stroke depression. Methods: Randomized controlled trials on pharmacopuncture treatment for post-stroke depression were searched from the China National Knowledge Infrastructure (CNKI). Literature searches of English and Chinese databases were performed. Selected literature was assessed with the Jadad scale. Results: Twelve papers were selected from 20 studies. The following results were obtained: 1) Pharmacopuncture was used for post-stroke depression; 2) Dengzhan-Xixin was the most used injection medicine for post-stroke depression; 3) BaiHui (GV20) was the most used in pharmacopuncture treatment; 4) Based on the Hamilton Depression Rating Scale (HAMD), it was confirmed that all studies using pharmacopunture had significant efficacy. Conclusions: For the treatment of post-stroke depression, Dengzhans-Xixin was commonly used as an injectable medication. Additional research studies on pharmacopuncture including its practical use are needed.

keywords
Post-stroke depression, Traditional Chinese medicine, Pharmacopuncture, Randomized controlled trial, Review

Journal of Oriental Neuropsychiatry